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Christopher A. Gallo, Jonathan M. Goodman, Beth E. Lewandowski, and William K. Thompson 
National Aeronautics and Space Administration 
Glenn Research Center 
Cleveland, Ohio 44135 
Summary 
Astronauts will be away from Earth-based medical care for long periods during future exploration 
missions. Thus, it will be necessary for the astronauts to perform various medical tasks to monitor and 
maintain their health in the microgravity environment of space. Performance of these tasks will be 
constrained due to the limited volume available to perform the task, the absence of gravity, and the 
limited resources and capabilities available in the medical work area. It is therefore necessary to evaluate 
exploration medical workstation designs to determine how well the designs will support crew 
performance of medical tasks. 
The Cross-cutting Computational Modeling Project (CCMP) team used biomechanical modeling and 
analysis tools to provide insight into the following questions:  
 
(1) What is the unrestricted operational volume needed to perform the medical procedures?  
(2) Is a smaller volume than the estimated unrestricted operational volume sufficient to perform the 
task? How much smaller? 
(3) How does the operational volume change when assistance is provided by another crew member 
during the medical procedure? 
(4) How much time is required to perform the medical procedures and the subtasks within the 
procedures?  
(5) How does the caregiver’s foot placement and ground reaction force change throughout the 
procedure?  
(6) If the caregiver’s feet are restricted in one or two locations, can the caregiver still perform the task? 
(7) What are the critical workspace dimensions? Can a tall caregiver and a shorter caregiver both 
work effectively within the workspace?  
(8) How many medical consumable resources does each medical procedure use?  
(9) How does the field of view change throughout the procedure? How often does the caregiver look 
at various parts of the medical station? 
(10) Which way does the caregiver’s head face in relation to his or her body throughout the procedure? 
(11) What is the caregiver’s opinion on the medical station layout? 
Methods 
Experimental Protocol 
Experimental testing occurred in the Exercise Countermeasures Laboratory (ECL) at NASA Glenn 
Research Center. Test subjects with professional medical training acted as caregivers and performed 
medical procedures on a medical manikin (Complete CRiSis™ Manikin, Nasco). Three subjects, one 
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male and two female, performed seven emergent medical procedures by themselves, and one procedure 
was performed by the male subject with one of the female subjects. The male subject (Subject 07), a 
pediatric surgeon, was in the 99th percentile for height. The first female subject (Subject 08), a physician 
assistant, was in the 26th percentile for height. The second female subject, a paramedic, was in the 94th 
percentile for height. The International Space Station (ISS) medical checklists were the source for these 
procedures, which are designed for spaceflight (Ref. 1). 
The following modified procedures were used for this analysis. Procedures 1 to 5 were performed in 
2018, and procedures 6 to 8 were performed in 2019. Subjects 07 and 08 performed all eight procedures, 
whereas Subject 09 only performed procedures 2 and 6 to 8. Additionally, Subject 09 performed 
procedure 2 with the patient vertical but without cardiopulmonary resuscitation (CPR) compressions. 
 
(1) Automated external defibrillator- (AED-) assisted CPR with one caregiver, pulse returns and 
patient becomes responsive (APR)  
(2) AED-assisted CPR with one caregiver with drug administration (ADA)  
(3) Choking patient becomes unconscious (CPU) 
(4) Abdominal ultrasound (AUL) examining a problem 
(5) AED-assisted CPR and advanced life support with two crew members 
(6) Intravenous fluid preparation and administration 
(7) Visual acuity exam 
(8) Optical coherence tomography (OCT) exam 
 
Copies of the modified procedures from the ISS medical checklists may be requested from the 
authors. The caregivers used handheld props representing medical tools and equipment while performing 
the procedures on the medical manikin.  
Four single-caregiver volume configurations and three dual-caregiver configurations were used, as 
illustrated in Figure 1. The test subjects performed the procedures without a volume restriction 
(unrestricted volume, URV) to obtain the task performance volume naturally used by the subject. The 
subjects repeated the procedures with restraints on the feet similar to those used on the ISS so that the 
subject’s feet stayed in only one or two positions (Figure 1(a)). Subjects 07 and 08 repeated the trials 
within two restricted working volumes (Figure 1(b) and 1(c)). The value for the first restricted volume 
(restricted volume large, RVL) was obtained from NASA Johnson Space Center. The second restricted 
volume (restricted volume small, RVS) was 64 percent of the first restricted volume (80 percent reduction 
in each dimension). A tubular framework outlined the restricted volumes within which the caregivers 
stayed. The rectangular framework adjusted from 127 to 254 cm (50 to 100 in.) per side. The framework 
was 193 cm (76 in.) in height but did not include overhead restrictions. In these analyses, the x-axis is in 
the main direction that the caregiver is facing, the y-axis is up, and the z-axis is along the length of the 
manikin. For all procedures, the RVL was 229 by 183 cm (90 by 72 in.) (z × x) and the RVS was 163 by 
145 cm (64 by 57 in.) (z × x). The medical manikin lay on a benchtop 152 by 51 cm (60 by 20 in.) (z × x) 
in area and 76 cm (30 in.) tall.  
For the dual-caregiver scenario performed by Subjects 07 and 08, the operational volume was not 
restricted, but the starting position of the caregivers varied among three positions. The subjects started the 
procedure on the same long side of the table (LLS; long–long, same side) (Figure 1(d)), on opposite long 
sides of the table (LLO; long–long, opposite sides) (Figure 1(e)), or crosswise on a long and a short side 
of the table (LSX; long–short, crosswise sides) (Figure 1(f)).  
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Figure 1.—Single-caregiver configurations ((a) to (c)) and dual-caregiver configurations ((d) to (f)). (a) Unrestricted 
volume with restricted feet. (b) Large restricted volume, 229 by 183 cm (90 by 72 in.). (c) Small restricted volume, 
163 by 145 cm (64 by 57 in.). (d) Long–long, same side of table (LLS). (e) Long–long, opposite sides of table 
(LLO). (f) Long–short, crosswise sides of table (LSX). 
 
 
 
The test matrices for the trials that occurred in 2018 and 2019 are given in Table I for the three 
subjects. The NASA Johnson Space Center Institutional Review Board (IRB) approved the experimental 
protocol. Subjects completed the IRB-approved informed consent form prior to any data collection. The 
Glenn Research Center Area 4 Safety Committee approved a safety permit for the activities. 
Data Collection and Experimental Measurements 
The ECL’s motion capture system (BTS Bioengineering Corp. 12-camera SMART DX 400) collected 
the motion data. Subjects 07 and 08 wore 33 reflective markers at key anatomical sites for use with the 
motion capture system; Subject 09 wore 27. For the two vision trials, the procedures were administered to 
a volunteer patient who wore 24 markers. The 33-marker system used appears in Figure 2. The marker 
names indicate their anatomical positions. 
Digital photographs with a ruler in the camera view documented the marker positions. The motion 
capture system collected motion data (three-dimensional coordinates of the test subject versus time) while 
the test subjects performed the medical tasks. Additional markers on the work area extremes outlined the 
restricted volumes. Two live video cameras recorded the subjects performing the procedures: one side 
view and one head-mounted view using a camera attached to a headband worn by the subject. 
The origin of the coordinate system was the posterior corner of the left force plate, relative to the 
subjects’ starting position facing the table from the left side of the manikin. The x-axis pointed forward, 
the y-axis pointed up, and the z-axis pointed toward the manikin’s head, as shown in Figure 3. 
In addition to operational volume data for the medical procedures, the motion capture system 
collected data for each subject’s maximum reach in all directions. The reported reach volume is the 
bounding box defined by the maximum extent of reach in all six directions (±X, ±Y, ±Z). 
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TABLE I.—TEST MATRICES FOR 2018 AND 2019 TRIALS 
(a) Subject 07 (S07)—August 17, 2018 
Trial Procedure Identification 
(ID) 
Configuration ID 
4 Choking patient becomes unconscious CPU Unrestricted volume URV 
6 Abdominal ultrasound AUL Unrestricted volume URV 
7 AED-assisted CPR, patient becomes responsive APR Restricted volume large RVL 
8 AED-assisted CPR with drug administration ADA Restricted volume large RVL 
9 Choking patient becomes unconscious CPU Restricted volume large RVL 
10 Abdominal ultrasound AUL Restricted volume large RVL 
11 Abdominal ultrasound AUL Restricted volume small RVS 
12 Choking patient becomes unconscious CPU Restricted volume small RVS 
13 Advanced lifesaving with drug administration ADA Restricted volume small RVS 
14 AED-assisted CPR, patient becomes responsive APR Restricted volume small RVS 
(b) Subject 08 (S08)—August 23, 2018 
Trial Procedure ID Configuration ID 
1 Abdominal ultrasound AUL Unrestricted volume URV 
2 Choking patient becomes unconscious CPU Unrestricted volume URV 
3 AED-assisted CPR, patient becomes responsive APR Unrestricted volume URV 
4 AED-assisted CPR with drug administration ADA Unrestricted volume URV 
5 AED-assisted CPR with drug administration ADA Restricted volume large RVL 
7 AED-assisted CPR, patient becomes responsive APR Restricted volume large RVL 
8 AED-assisted CPR, patient becomes responsive APR Restricted volume small RVS 
9 Abdominal ultrasound AUL Restricted volume large RVL 
10 Abdominal ultrasound AUL Restricted volume small RVS 
11 Choking patient becomes unconscious CPU Restricted volume large RVL 
12 Choking patient becomes unconscious CPU Restricted volume small RVS 
(c) Subject 08 (S08)—September 7, 2018 
Trial Procedure ID Configuration ID 
1 Abdominal ultrasound AUL Restricted feet RFT 
2 Choking patient becomes unconscious CPU Restricted feet RFT 
3 AED-assisted CPR, patient becomes responsive APR Restricted feet RFT 
4 AED-assisted CPR with drug administration ADA Restricted feet RFT 
(d) Subject 07 (S07)—September 26, 2018 
Trial Procedure ID Configuration ID 
1 Abdominal ultrasound AUL Restricted feet RFT 
2 Choking patient becomes unconscious CPU Restricted feet RFT 
3 AED-assisted CPR, patient becomes responsive APR Restricted feet RFT 
4 AED-assisted CPR with drug administration ADA Restricted feet RFT 
1 AED-assisted CPR, patient becomes responsive APR Unrestricted volume URV 
2 AED-assisted CPR with drug administration ADA Unrestricted volume URV 
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TABLE I.—Concluded.  
(e) Subjects 07 and 08—October 19, 2018 
Trial Procedure ID Configuration ID 
6 AED-assisted CPR with drug administration ADA Restricted volume small RVS 
1 AED-assisted CPR with two crew members AC2 Long–long same side LLS 
2 AED-assisted CPR with two crew members AC2 Long–long opposite side LLO 
3 AED-assisted CPR with two crew members AC2 Long–short side LSX 
(f) Subject 07 (S07)—May 14, 2019 
Trial Procedure ID  Configuration  ID 
1 Intravenous fluid preparation and administration IVF Unrestricted volume URV 
2 Intravenous fluid preparation and administration IVF Restricted feet RFT 
3 Visual acuity VIS Restricted feet RFT 
4 Optical coherence tomography OCT Unrestricted volume URV 
5 Optical coherence tomography OCT Restricted feet RFT 
(g) Subject 08 (S08)—May 28, 2019 
Trial Procedure ID Configuration ID  
1 Intravenous fluid preparation and administration IVF Unrestricted volume URV 
2 Intravenous fluid preparation and administration IVF Restricted feet RFT 
3 Visual acuity VIS Restricted feet RFT 
4 Optical coherence tomography OCT Unrestricted volume URV 
5 Optical coherence tomography OCT Restricted feet RFT 
(h) Subject 09 (S09)—August 2, 2019 
Trial Procedure ID Configuration ID 
1 Intravenous fluid preparation and administration IVF Unrestricted volume URV 
2 Intravenous fluid preparation and administration IVF Restricted feet RFT 
3 AED-assisted CPR with drug administration ADA Unrestricted volume URV 
4 AED-assisted CPR with drug administration ADA Restricted feet RFT 
5 AED-assisted CPR with drug administration ADA Patient vertical VRT 
6 Visual acuity VIS Restricted feet RFT 
7 Optical coherence tomography OCT Unrestricted volume URV 
8 Optical coherence tomography OCT Restricted feet RFT 
 
 
Additional data collected included heart rate (Zephyr HxM, Medtronics, Subjects 07 and 08 only), 
the time to perform the procedures, and the quantity of resources used. The subjects provided subjective 
feedback, including completion of a NASA task load index (TLX) survey of workload, a System 
Usability Scale (SUS), and an open-ended assessment questionnaire.  
Reference 2 describes the NASA TLX factors, and Reference 3 describes the SUS. The open-ended 
assessment questions appear in Appendix B. Figure 4 illustrates the process flow from data collection and 
analysis to results plot creation. 
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Figure 2.—Anatomical positions of 33 reflective markers used for motion capture by BTS Bioengineering system. 
 
Post-Testing Analysis Methods 
Maximum XYZ Bounding Box 
For all of the procedures performed, the maximum and minimum body marker coordinate along each 
axis determined the maximum XYZ operational volume. Comparative analyses between volumes 
included unrestricted versus large and small restricted versus restricted feet; all volumes versus the NASA 
Johnson Space Center CTV database volume; and large male versus petite female. 
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Figure 3.—Side view of test setup. Colored arrows depict origin and coordinate system for motion capture. 
(a) Setup for Subject 07, tall male. (b) Setup for Subject 08, petite female. Wooden box under female subject’s 
feet positions her more advantageously for doing CPR compressions. (c) Setup for Subject 09, tall female. 
 
 
 
Figure 4.—Exploration medical station analysis process.  
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Figure 5.—Computation of convex volume using QuickHull method. (a) X, Y, and Z coordinates for each marker are 
obtained at every time step and accumulated over a period of time to form a point cloud. (b) QuickHull algorithm 
computes convex hull (i.e., outermost points of this point cloud). Surface is generated from these outermost points 
and volume within is calculated. 
Heat Map and Convex Volume 
Custom Python code generated the heat maps that trace the XYZ position of every marker through 
space. The coordinates for each marker at every time step define and form a point cloud. Brighter colors 
in the resulting image indicate areas of greater marker density over time at a specific XYZ location in the 
volume. Three views (XY, XZ, and YZ) define the point cloud volume in all three dimensions. The 
outermost points of the cloud determine a surface. The convex volume is the volume within that surface. 
The software computes the convex volume of the resulting surface using the QuickHull method in 
Python, as depicted in Figure 5. 
Foot Placement Map 
The foot placement map is a heat map of just the foot markers observed in the XZ plane for the 
duration of each procedure. The force plate positions appear on the foot placement map as adjacent 
rectangles. 
Activity-Dependent Volume 
After manual segmentation of each procedure by activity, the Behavioral Observation Research 
Interactive Software (BORIS) (Ref. 4) generated a timeline plot of the subtasks of the procedures. 
Superimposed on this timeline are the cumulative operational volume, the intervals where reaching 
activities (i.e., not caregiving) occurred, and a plot of the subject’s heart rate.  
Credibility Assessment and Reviews 
The NASA Standard 7009A compliance analysis for this task appears in Appendix C. 
Results 
Operational Volumes 
Subjects 07 and 08 were able to perform all of the procedures within the large and small restricted 
volumes without interferences, except for the intubation portion of the choking procedure while in the 
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smaller restricted volume. Interestingly, the volume used by the subjects was smaller for the restricted 
volumes than for the unrestricted, even though they did not experience interference with the restricting 
panels. Subject 08, the petite female, used relatively large volumes during some of the unrestricted 
volume trials, approximately twice the volume used by Subject 07, the tall male. When these volumes 
were not included, the operational volume used by the petite female was, on average, 83 percent of the 
volume used by the tall male. Subject 09 only performed procedures in the unrestricted volume. The 
volume used by Subject 09, the tall female, was typically less than that used by the tall male when the 
same procedures were performed by the three subjects. The operational volume used by the tall female 
was, on average, 91 percent of the volume used by the tall male. 
Table II to Table IV list the rectangular cuboid volume and convex volume calculated for the subjects 
for each procedure. Figure 6 to Figure 10 illustrate this table for each subject in bar graph form. 
Illustrations of the estimated convex hull volumes appear in Figure 11 to Figure 17 for Subject 07 and in 
Figure 18 to Figure 24 for Subject 08, and in Figure 25 for the dual-caregiver trial. Convex hull volume 
illustrations for the 2019 testing appear in Figure 26 to Figure 30 for Subject 07, Figure 31 to Figure 35 
for Subject 08 and Figure 36 to Figure 43 for Subject 09. The convex hull volume defines an envelope 
that fully encloses all of the subject’s markers during the entire procedure. The convex hull volume 
represents the outline of the volume occupied by the person performing the task and is less than the 
conservative bounding rectangular cuboid volume. The maximum cuboid volume appears as a red box.  
The AED procedure with drug administration (ADA) was performed by Subjects 07 and 08 together. 
They performed three trials, the difference being the starting location of the caregivers in relation to the 
manikin. During all three procedures, the caregivers moved to and ended in locations based on the care 
they needed to provide. For all three procedures, the ending position was with one subject on a long side 
and the other on the short side of the table where the manikin’s head was located. The operational volume 
used during the dual-caregiver procedure was approximately twice the volume when a single caregiver 
performed the procedure, based on the trial where the starting and ending location of the caregivers was 
the same. The convex hull volume for the dual-caregiver trial appears in Figure 25. 
Figure 44 depicts a perspective view of the marker-trace point cloud for Subject 07 at one instant of 
time during the ADA procedure. The markers appear connected to facilitate visualization. Note that the 
densest areas of point concentration occur in the position where the caregiver is performing chest 
compressions during CPR. 
 
TABLE II.—SUBJECT 07 VOLUME SUMMARY—2018 TESTING 
Volume,  
m3 
AEDa drug 
administration 
AED pulse 
returns 
Abdominal 
ultrasound 
Choking patient 
becomes unconscious 
Reach 
Rectangular 
Unrestricted 4.1 2.7 3.4 7.5 --- 
Large 4.2 4.1 3.3 4.8 --- 
Small 3.2 3.1 2.4 3.2 --- 
Restricted feet 3.0 2.7 2.5 6.4 6.3 
Convex 
Unrestricted 2.1 1.4 1.7 6.3 --- 
Large 2.1 2.0 1.7 2.5 --- 
Small 1.7 1.6 1.3 1.6 --- 
Restricted feet 1.3 1.2 1.0 2.7 --- 
Crew Task Volume Database 10.5 10.5 9.8 8.7 --- 
aAutomated external defibrillator. 
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TABLE III.—SUBJECT 08 VOLUME SUMMARY—2018 TESTING 
Volume,  
m3 
AEDa drug 
administration 
AED pulse 
returns 
Abdominal 
ultrasound 
Choking patient 
becomes unconscious Reach 
Rectangular 
Unrestricted 10.6 5.5 2.9 10.9 --- 
Large 3.1 2.9 2.6 3.8 --- 
Small 3.1 2.8 1.9 2.7 --- 
Restricted feet 2.9 2.8 2.3 4.3 3.4 
Convex 
Unrestricted 5.7 2.6 1.2 5.9 --- 
Large 1.5 1.4 1.1 1.9 --- 
Small 2.0 1.4 1.0 1.2 --- 
Restricted feet 1.3 1.1 0.7 1.8 --- 
Crew Task Volume Database 10.5 10.5 9.8 8.7 --- 
aAutomated external defibrillator 
 
 
 
 
TABLE IV.—SUBJECT 07 VOLUME SUMMARY—2019 TESTING 
Volume,  
m3 
Intravenous fluid 
preparation and 
administration 
Visual acuity 
exam 
Optical coherence 
tomography (OCT) 
exam 
Caregiver 
and patient 
Rectangular 
Unrestricted --- --- 4.8 
Restricted feet --- 3.4 2.5 
Convex 
Unrestricted --- --- 2.5 
Restricted feet --- 1.3 1.2 
Caregiver 
Rectangular 
Unrestricted 3.9 --- 3.7 
Restricted feet 2.3 1.5 1.6 
Convex 
Unrestricted 2.3 --- 2.0 
Restricted feet 1.1 0.6 0.8 
Patient 
Rectangular 
Unrestricted --- --- 0.4 
Restricted feet --- 0.6 0.3 
Convex 
Unrestricted --- --- 0.2 
Restricted feet --- 0.2 0.2 
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TABLE V.—SUBJECT 08 VOLUME SUMMARY—2019 TESTING 
Volume,  
m3 
Intravenous fluid 
preparation and 
administration 
Visual acuity exam Optical coherence 
tomography (OCT) 
exam 
Caregiver 
and patient 
Rectangular 
Unrestricted --- --- 1.7 
Restricted feet --- 2.3 1.6 
Convex 
Unrestricted --- --- 0.9 
Restricted feet --- 0.9 0.9 
Caregiver 
Rectangular 
Unrestricted 3.9 --- 1.0 
Restricted feet 2.8 1.3 0.9 
Convex 
Unrestricted 1.6 --- 0.5 
Restricted feet 1.0 0.5 0.4 
Patient 
Rectangular 
Unrestricted --- --- 0.4 
Restricted feet --- 0.7 0.4 
Convex 
Unrestricted --- --- 0.2 
Restricted feet --- 0.3 0.2 
 
 
 
TABLE VI.—SUBJECT 09 VOLUME SUMMARY—2019 TESTING 
Volume,  
m3 
Intravenous fluid 
preparation and 
administration 
Visual acuity 
exam 
Optical coherence 
tomography (OCT) 
exam 
AEDa drug 
administration 
Caregiver 
and patient 
Rectangular 
Unrestricted --- --- 3.7 --- 
Restricted feet --- 2.7 2.5 --- 
Convex 
Unrestricted --- --- 2.1 --- 
Restricted feet --- 1.2 1.2 --- 
Caregiver 
Rectangular 
Unrestricted 2.0 --- 2.8 3.9 
Restricted feet 2.1 1.9 1.5 2.6 
Vertical --- --- --- 3.1 
Convex 
Unrestricted 0.8 --- 1.4 1.6 
Restricted feet 0.8 0.7 0.6 1.2 
Vertical --- --- --- 1.8 
Patient 
Rectangular 
Unrestricted --- --- 0.6 --- 
Restricted feet --- 0.8 0.4 --- 
Convex 
Unrestricted --- --- 0.3 --- 
Restricted feet --- 0.3 0.2 --- 
aAutomated external defibrillator 
 
 
 
NASA/TM—2020-220149 12 
 
Figure 6.—Summary of volumes for all procedures performed by Subject 07 in 2018 testing. 
Automated external defibrillator, AED. (a) Rectangular volume. (b) Convex volume. 
 
 
 
Figure 7.—Summary of volumes for all procedures performed by Subject 08 in 2018 testing. 
Automated external defibrillator, AED. (a) Rectangular volume. (b) Convex volume. 
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Figure 8.—Summary of volumes for all procedures performed by Subject 07 in 2019 testing. Intravenous, IV. Optical 
coherence tomography, OCT. (a) Rectangular volume. (b) Convex volume. 
 
 
 
Figure 9.—Summary of volumes for all procedures performed by Subject 08 in 2019 testing. Intravenous, IV. Optical 
coherence tomography, OCT. (a) Rectangular volume. (b) Convex volume. 
 
 
 
Figure 10.—Summary of volumes for all procedures performed by Subject 09 in 2019 testing. Intravenous, IV. 
Optical coherence tomography, OCT. Automated external defibrillator, AED. (a) Rectangular volume. (b) Convex 
volume. 
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Figure 11.—Subject 07, large restricted volume, automated external defibrillator (AED) 
pulse returns procedure. (a) Front. (b) Side. (c) Top. (d) Top, feet only. 
 
 
Figure 12.—Subject 07, small restricted volume, automated external defibrillator (AED) 
pulse returns procedure. (a) Front. (b) Side. (c) Top. (d) Top, feet only.  
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Figure 13.—Subject 07, restricted feet, automated external defibrillator (AED) pulse returns 
procedure. (a) Front. (b) Side. (c) Top. (d) Top, feet only. 
 
 
Figure 14.—Subject 07, unrestricted volume, automated external defibrillator (AED) pulse 
returns procedure. (a) Front. (b) Side. (c) Top. (d) Top, feet only.  
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Figure 15.—Subject 07, unrestricted volume, automated external defibrillator (AED) with 
drug administration procedure. (a) Front. (b) Side. (c) Top. (d) Top, feet only. 
 
 
Figure 16.—Subject 07, unrestricted volume, choking patient becomes unconscious 
procedure. (a) Front. (b) Side. (c) Top. (d) Top, feet only.  
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Figure 17.—Subject 07, unrestricted volume, abdominal ultrasound procedure. (a) Front. 
(b) Side. (c) Top. (d) Top, feet only. 
 
 
Figure 18.—Subject 08, large restricted volume, automated external defibrillator (AED) 
pulse returns procedure. (a) Front. (b) Side. (c) Top. (d) Top, feet only.  
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Figure 19.—Subject 08, small restricted volume, automated external defibrillator (AED) 
pulse returns procedure. (a) Front. (b) Side. (c) Top. (d) Top, feet only. 
 
 
Figure 20.—Subject 08, restricted feet, automated external defibrillator (AED) pulse returns 
procedure. (a) Front. (b) Side. (c) Top. (d) Top, feet only.  
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Figure 21.—Subject 08, unrestricted volume, automated external defibrillator (AED) pulse 
returns procedure. (a) Front. (b) Side. (c) Top. (d) Top, feet only. 
 
 
Figure 22.—Subject 08, unrestricted volume, automated external defibrillator (AED) with 
drug administration procedure. (a) Front. (b) Side. (c) Top. (d) Top, feet only.  
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Figure 23.—Subject 08, unrestricted volume, choking patient becomes unconscious 
procedure. (a) Front. (b) Side. (c) Top. (d) Top, feet only. 
 
 
Figure 24.—Subject 08, unrestricted volume, abdominal ultrasound procedure. (a) Front. 
(b) Side. (c) Top. (d) Top, feet only   
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Figure 25.—Dual caregiver, unrestricted volume, automated external defibrillator (AED) 
with drug administration procedure. (a) Front. (b) Side. (c) Top. (d) Top, feet only. 
 
 
Figure 26.—Subject 07, unrestricted volume, intravenous fluid preparation and 
administration procedure. (a) Front. (b) Side. (c) Top. (d) Top, feet only.  
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Figure 27.—Subject 07, restricted feet, intravenous fluid preparation and administration 
procedure. (a) Front. (b) Side. (c) Top. (d) Top, feet only. 
 
 
Figure 28.—Subject 07, restricted feet, visual acuity procedure. (a) Front. (b) Side. (c) Top. 
(d) Top, feet only. 
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Figure 29.—Subject 07, unrestricted volume, optical coherence tomography (OCT) 
procedure. (a) Front. (b) Side. (c) Top. (d) Top, feet only. 
 
 
Figure 30.—Subject 07, restricted feet, optical coherence tomography (OCT) procedure. 
(a) Front. (b) Side. (c) Top. (d) Top, feet only.  
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Figure 31.—Subject 08, unrestricted volume, intravenous fluid preparation and 
administration procedure. (a) Front. (b) Side. (c) Top. (d) Top, feet only. 
 
 
Figure 32.—Subject 08, restricted feet, intravenous fluid preparation and administration 
procedure. (a) Front. (b) Side. (c) Top. (d) Top, feet only.  
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Figure 33.—Subject 08, restricted feet, visual acuity procedure. (a) Front. (b) Side. (c) Top. 
(d) Top, feet only. 
 
 
Figure 34.—Subject 08, unrestricted volume, optical coherence tomography (OCT) 
procedure. (a) Front. (b) Side. (c) Top. (d) Top, feet only.  
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Figure 35.—Subject 08, restricted feet, optical coherence tomography (OCT) procedure. 
(a) Front. (b) Side. (c) Top. (d) Top, feet only. 
 
 
Figure 36.—Subject 09, unrestricted volume, intravenous fluid preparation and 
administration procedure. (a) Front. (b) Side. (c) Top. (d) Top, feet only.  
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Figure 37.—Subject 09, restricted feet, intravenous fluid preparation and administration 
procedure. (a) Front. (b) Side. (c) Top. (d) Top, feet only. 
 
 
Figure 38.—Subject 09, restricted feet, visual acuity procedure. (a) Front. (b) Side. (c) Top. 
(d) Top, feet only. 
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Figure 39.—Subject 09, unrestricted volume, optical coherence tomography (OCT) 
procedure. (a) Front. (b) Side. (c) Top. (d) Top, feet only. 
 
 
Figure 40.—Subject 09, restricted feet, optical coherence tomography (OCT) procedure. 
(a) Front. (b) Side. (c) Top. (d) Top, feet only.  
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Figure 41.—Subject 09, unrestricted volume, automated external defibrillator (AED) with 
drug administration (ADA) procedure. (a) Front. (b) Side. (c) Top. (d) Top, feet only. 
 
 
Figure 42.—Subject 09, restricted feet, automated external defibrillator (AED) with drug 
administration (ADA) procedure. (a) Front. (b) Side. (c) Top. (d) Top, feet only.  
NASA/TM—2020-220149 30 
 
 
 
 
 
 
 
 
 
 
 
Figure 43.—Subject 09, patient vertical, automated external defibrillator (AED) with drug 
administration procedure. (a) Front. (b) Side. (c) Top. (d) Top, feet only. 
 
NASA/TM—2020-220149 31 
 
Figure 44.—Marker trace for Subject 07, unrestricted volume, automated external 
defibrillator (AED) with drug administration procedure. 
Foot Placement 
The subjects successfully performed all procedures with their feet restricted. The limiting factor with 
the feet in the foot restraints was the extent to which caregivers had to reach for equipment and supplies, 
which were all within reach for these procedures. If the subjects had to reach for equipment in cabinets or 
drawers located in and around the workstation, they would potentially have to leave the foot restraints to 
retrieve the items. The maximum extent of the reach volume was 6.3 m3 (221 ft3) for Subject 07 and 
3.4 m3 (120 ft3) for Subject 08. Figure 45 compares the reach volume with the restricted foot rectangular 
cuboid volume for the four procedures. 
Time Required to Perform Procedures and Resources Used 
BORIS event plots of the various procedures appear in Figure 46 to Figure 52 for the 2018 testing and 
Figure 53 to Figure 70 for the 2019 testing. The plots denote when subprocedures occurred and when 
subjects provided care versus when subjects reached for items. The event plots also include the heart rate 
data plotted for the trial for Subjects 07 and 08 for 2018 testing only. Subject 07 had a relatively steady 
heart rate throughout the procedures, with an overall average of 67 bpm and standard deviation between 
2.2 and 4.5, depending on the trial. Subject 08 had an overall average of 95 bpm with standard deviation 
between 2.2 and 9.6. Subject 08 had a higher heart rate for the AED procedures, with the heart rate 
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peaking while performing CPR, whereas Subject 07 typically had a steady heart rate over the entire 
procedure. Heart rate data for the dual-caregiver procedures was available for Subject 08 only. The 
average heart rate was 87 bpm for the three trials, with a standard deviation range from 2.2 to 5.8.  
Table VII includes the heart rate summary for all trials. The overall time required to perform each 
procedure appears in Table VIII. The resources and equipment used in each procedure appear in Table IX. 
As the caregivers became more experienced at performing the procedures, their elapsed time decreased. 
Additionally, the procedures streamlined as the test operators also became more experienced. 
 
 
 
 
Figure 45.—Rectangular volume comparison, reach with caregiver stationary versus restricted feet 
trials. Automated external defibrillator, AED. 
 
 
 
 
Figure 46.—Subject 07, unrestricted volume, automated external defibrillator (AED) with drug administration (ADA) 
procedure. Cardiopulmonary resuscitation, CPR; intravenous, IV. 
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Figure 47.—Subject 08, unrestricted volume, automated external defibrillator (AED) with drug administration (ADA) 
procedure. Cardiopulmonary resuscitation, CPR. 
 
 
 
Figure 48.—Subject 07, small restricted volume, automated external defibrillator (AED) pulse returns (APR) 
procedure. Cardiopulmonary resuscitation, CPR. Intravenous, IV. 
 
 
 
Figure 49.—Subject 08, large restricted volume, automated external defibrillator (AED) pulse returns (APR) 
procedure. Cardiopulmonary resuscitation, CPR. Intravenous, IV. 
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Figure 50.—Subject 07, restricted feet, choking patient becomes unconscious (CPU) procedure. Cardiopulmonary 
resuscitation, CPR.  
 
 
 
 
 
 
Figure 51.—Subject 08, large restricted volume, choking patient becomes unconscious (CPU) procedure. 
Cardiopulmonary resuscitation, CPR. 
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Figure 52.—Dual caregiver, automated external defibrillator (AED) with drug administration (ADA) procedure.                
(a) Subject 07. (b) Subject 08. 
 
 
 
 
Figure 53.—Subject 07, unrestricted volume, intravenous (IV) fluid preparation and administration procedure. 
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Figure 54.—Subject 08, unrestricted volume, intravenous (IV) fluid preparation and administration procedure. 
 
 
Figure 55.—Subject 09, unrestricted volume, intravenous (IV) fluid preparation and administration procedure. 
 
 
Figure 56.—Subject 07, restricted feet, intravenous (IV) fluid preparation and administration procedure. 
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Figure 57.—Subject 08, restricted feet, intravenous (IV) fluid preparation and administration procedure. 
 
 
Figure 58.—Subject 09, restricted feet, intravenous (IV) fluid preparation and administration procedure. 
 
 
Figure 59.—Subject 07, restricted feet, visual acuity procedure. 
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Figure 60.—Subject 08, restricted feet, visual acuity procedure. 
 
 
Figure 61.—Subject 09, restricted feet, visual acuity procedure. 
 
 
Figure 62.—Subject 07, unrestricted volume, optical coherence tomography (OCT) procedure. 
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Figure 63.—Subject 08, unrestricted volume, optical coherence tomography (OCT) procedure. 
 
 
Figure 64.—Subject 09, unrestricted volume, optical coherence tomography (OCT) procedure. 
 
 
Figure 65.—Subject 07, restricted feet, optical coherence tomography (OCT) procedure. 
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Figure 66.—Subject 08, restricted feet, optical coherence tomography (OCT) procedure. 
 
 
 
Figure 67.—Subject 09, restricted feet, optical coherence tomography (OCT) procedure. 
 
 
 
Figure 68.—Subject 09, unrestricted volume, automated external defibrillator (AED) with drug administration (ADA) 
procedure. 
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Figure 69.—Subject 09, restricted feet, automated external defibrillator (AED) with drug administration (ADA) 
procedure. 
 
 
 
 
 
 
Figure 70.—Subject 09, patient vertical, automated external defibrillator (AED) with drug administration (ADA) 
procedure. 
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TABLE VII.—HEART RATE DATA 
(a) Single caregiver. 
  
Average heart rate, bpm 
Volume Restricted 
feet Unrestricted Large Small 
Subject 07 
AEDa with drug administration  68±2.6 69±3.3 67±3.5 69±2.7 
AED pulse returns  69±2.7 66±2.5 69±2.4 70±3.0 
Choking patient becomes unconscious NA 67±3.5 68±3.3 74±4.0 
Abdominal ultrasound 61±2.3 66±2.4 65±2.2 73±2.4 
Subject 08 
AED with drug administration 102±8.7 104±9.6 97±6.0 97±8.7 
AED pulse returns 89±6.5 93±7.1 94±7.6 90±9.4 
Choking patient becomes unconscious 97±7.7 96±7.1 96±5.8 100±9.4 
Abdominal ultrasound 91±4.0 89±4.3 88±2.8 92±5.3 
(b) Dual caregiver, AED with drug administration 
procedure, unrestricted volume. 
Table start position Average heart rate, bpm 
Long–long, same side 86±4.6 
Long–long, opposite sides 82±2.2 
Long–short, crosswise sides  91±5.8 
aAutomated external defibrillator. 
 
TABLE VIII.—PROCEDURE TIMES 
(a) Single caregiver. 
  
Time to perform procedures, min 
Volume Restricted 
feet Unrestricted Large Small 
Subject 07 
AEDa with drug administration 8.4 11.0 9.9 9.2 
AED pulse returns 4.1 6.1 4.7 5.6 
Choking patient becomes unconscious 1.7 5.3 3.7 3.5 
Abdominal ultrasound 8.2 5.9 5.3 4.5 
Subject 08 
AED with drug administration 10.7 9.8 5.2 9.7 
AED pulse returns 9.0 5.9 5.4 4.8 
Choking patient becomes unconscious 4.7 3.7 3.0 3.6 
Abdominal ultrasound 5.0 4.2 4.2 5.5 
(b) Dual caregiver, AED with drug administration 
procedure, unrestricted volume. 
Table start position Time, min 
Long–long, same side  3.6 
Long–long, opposite sides  2.6 
Long–short, crosswise sides  2.5 
aAutomated external defibrillator. 
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TABLE IX.—PROCEDURE EQUIPMENT LIST 
Choking patient becomes 
unconscious 
Abdominal ultrasound Both automated external 
defibrillator (AED) 
procedures 
Additional equipment for 
AED with drug 
administration 
Oral airway kit Ultrasound AED trainer Intraosseous device 
Blood pressure cuff Ultrasound probe AED electrodes Epinephrine syringe 
Stethoscope Keyboard simulation Cardiopulmonary 
resuscitation (CPR) mask 
Atropine syringe 
Blood oximeter Benzalkonium (BZK) wipe Medical tape Lidocaine syringe 
Laryngoscope Thermometer Stethoscope  
Forceps Blood pressure monitor Blood oximeter  
Endotracheal tube Blood pressure cuff  AMBU bag  
Flashlight Stethoscope Non-rebreather mask  
Artificial manual breathing 
unit (AMBU) bag 
Laptop Electrocardiogram (ECG) 
device 
 
  
ECG lead set cable    
Electrode package    
Zip-lock bag    
Intravenous (IV) cap    
IV bag    
Tourniquet  
Subjective Feedback 
NASA Task Load Index Feedback 
There was high intrasubject variability even when the subjects’ open-ended feedback suggested that 
the volume changes made no difference.  
AED procedures: A summary of the NASA TLX responses for these procedures for 2018 testing 
appears in Figure 71. For the male subject, temporal and mental demand are both consistently high 
factors. For the female subject, temporal demand is higher, and frustration is sometimes higher. Overall, 
reducing the volume seemed to lower the ratings rather than increase them. This was not expected, but it 
may be attributable to the subjects’ learning the procedures as they repeated them. 
Non-AED procedures: A summary of the NASA TLX responses for these procedures for 2018 testing 
appears in Figure 72. Subject 07 rated frustration very high. The subject mentioned the lack of fidelity in 
feedback as a major contributing factor to his frustration. Subject 08 rated all of the TLX factors high for 
the large-volume trials. An explanation for this was not obvious. 
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Figure 71.—NASA task load index score for automatic external defibrillator- (AED-) based procedures (AED pulse 
returns, AED with drug administration, and dual-caregiver AED); 2018 testing. Unrestricted volume, URV; restricted 
volume large, RVL; restricted volume small, RVS; restricted feet, RFT; long–long, same side of table, LLS; long–
long, opposite sides of table, LLO; long–short, crosswise sides of table, LSX. (a) Subject 07, tall male. (b) Subject 
08, petite female. 
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Figure 72.—NASA task load index scores for non-AED-based procedures; 2018 testing. Unrestricted volume, URV; 
restricted volume large, RVL; restricted volume small, RVS; restricted feet, RFT. (a) Subject 07, tall male.             
(b) Subject 08, petite female. 
 
Intravenous Fluid Preparation and Administration: Figure 73 to Figure 75 summarize the NASA 
TLX responses for these procedures for Subject 07, Subject 08, and Subject 09. All three subjects rated 
the temporal demand highest even though this was not a timed procedure. Subject 09 rated the mental 
demand and frustration high for this trial in the unrestricted volume. Restricting the feet had no effect for 
Subject 07, whose ratings for restricted feet and unrestricted volume were approximately the same. 
Subject 08 preferred the unrestricted volume and Subject 09 preferred restricted feet. 
Visual Acuity Exam—Restricted Feet Only (Figure 73 to Figure 75): Subject 07 appeared not to prefer 
the feet restricted for this trial. Mental demand was highest for Subject 08. Subject 09 rated time and 
effort highest. 
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Figure 73.—NASA task load index score for Subject 07; 2019 testing. 
 
 
Figure 74.—NASA task load index score for Subject 08; 2019 testing. Intravenous, IV. 
 
 
 
Optical Coherence Tomography (OCT) Exam (Figure 73 to Figure 75): Subject 07 required higher 
physical and mental demand. Subject 08 appeared relaxed for both trials. Time was a factor for Subject 09 
when unrestricted, and Subject 09 rated frustration high when the feet were restricted. 
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Figure 75.—NASA task load index score for Subject 09; 2019 testing. Intravenous, IV. 
 
 
 
 
Figure 76.—NASA task load index score for Subject 09 for automated 
external defibrillator- (AED-) based procedures; 2019 testing. 
 
 
AED with Drug Administration—Subject 09 Only: NASA TLX ratings for these procedures are 
summarized in Figure 76. Subject 09 was comfortable performing all three AED trials, probably due to a 
background as a paramedic.  
System Usability Scale Feedback 
SUS responses for all procedures are summarized in Figure 77 to Figure 80. Based on research  
(Ref. 2), a SUS score above a 68 would be an above-average usability score and anything below 68 is 
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below average (Ref. 3). The petite female found the space more usable overall than the tall male did. 
Restricting the volume or the feet tended to reduce the SUS score slightly. The dual-caregiver scenario 
raised the SUS score for the male, but not for the female. Generally, all three subjects did not discern 
between the unrestricted volume and restricted feet. For the AED procedures, Subject 09 rated the 
restricted feet trial slightly higher than the unrestricted (83 versus 75) and gave the vertical manikin a low 
score (38) due to the abnormal vertical position. Subject 07 (physician) ratings were around average, 
whereas Subject 09 (paramedic) ratings were above average and Subject 08 (physician’s assistant) ratings 
were high for the 2019 trials. 
 
 
 
 
Figure 77.—System Usability Scale (SUS) data for all procedures; 2018 testing. Unrestricted volume, URV; restricted 
volume large, RVL; restricted volume small, RVS; restricted feet, RFT; automated external defibrillator, AED; long–
long, same side of table, LLS; long–long, opposite sides of table, LLO; long–short, crosswise sides of table, LSX. 
(a) Subject 07, tall male. (b) Subject 08, petite female. 
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Figure 78.—System Usability Scale (SUS) data for Subject 07; 2019 testing. Intravenous, IV. 
 
 
 
Figure 79.—System Usability Scale (SUS) data for Subject 08; 2019 testing. Intravenous, IV. 
 
 
 
Figure 80.—System Usability Scale (SUS) data for Subject 09; 2019 testing. Intravenous, IV. Automated external 
defibrillator, AED. 
NASA/TM—2020-220149 50 
Open-Ended Feedback 
The following is a summary of the significant responses to the open-ended questions: 
 
• Low-fidelity simulation generally inhibited the ability to truly simulate emergent care. 
• Suggested improvements included using more realistic intubation equipment and real ultrasound 
images.  
• Access to the patient’s head with sightline down the airway is critical for intubation and bag mask 
procedures. This is a very important factor to consider for design in small restricted volumes. 
How will this be achieved in a microgravity environment? 
• A dual-caregiver approach was more effective for all procedures and tasks, especially when chest 
compressions must be performed. 
• Ultrasound machine placement in relation to the patient must factor in the dominant hand of the 
caregiver. In particular, the ultrasound probe should be in the dominant hand and the patient 
should be on the side of the caregiver’s dominant hand. 
• It was difficult to remove air from the IV bag and prime the tubing with liquid while also holding 
the bag for the IV procedure. Securing the tubing and bag while priming would help. 
• Additional equipment may be required to find the vein for IV placement if the patient is ill. 
• Not enough height to perform CPR compressions with the patient horizontal on the table. 
• It would be difficult to perform CPR compressions with the patient vertical. It was difficult to use 
the AMBU bag with the patient vertical. (CPR was not performed on the vertical patient.) 
• With restricted feet 
○ Supplies must be placed within the caregiver’s reach space and near the part of the patient’s 
body where used (e.g., intubation supplies near the head and intraosseous supplies near the 
legs). 
○ An easy way to translate from the patient’s side to the patient’s head should be factored into 
the design. 
• There should be ways to temporarily hold equipment in place to free up the caregiver’s hands, 
especially for intubation. 
• What do you do after the first 10 min of care? How do you provide ongoing care in the 
environment? 
• Getting input from ER nurses and EMS/paramedics is highly recommended. They would be able 
to give better insight into space design and equipment layout and doing emergency procedures in 
limited-resource environments. 
Discussion and Key Findings 
Restricting the volume with an external barrier did not necessarily affect completion of the task or the 
time required to perform it, with the exception of intubation procedures. Intubation requires visual access 
to the subject’s airway, looking down the throat from behind the head. Restricting the volume to limit this 
access makes the procedure more difficult for the caregiver and likely more risky for the patient. 
The operational volume tends to be mushroom-shaped (i.e., much more upper body movement), 
especially with restricted feet. The presence of restricted volume, or even the caregiver’s perception of 
restricted volume, reduced the actual operational volume. Note that the subjects did not receive verbal 
prompting to be aware of their operational volume. Even when the unrestricted volume fits within the 
imposed volume, the resulting operational volume will diminish with restrictions in place.  
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The volume needed for performing caregiving operations is significantly smaller than the total 
volume with reaching for supplies or equipment factored in. The design of the workstation and the 
placement of supplies and equipment relative to where they are needed will drive the true operational 
volume. The smallest possible operational volume of any candidate medical station design will likely lie 
between the unrestricted operational volume and the volume occupied when performing caregiving only 
(i.e., with all reaching operations eliminated). 
Subject 07 and Subject 08 occupied about the same volume for the IV procedure with the volume 
unrestricted, but Subject 09 occupied half the volume of the other subjects. Subject 09 used about 
35 percent more average volume for the visual acuity with the feet restricted, which was probably due to 
greater reaching length. Subject 07 and 09 used about the same volume for the unrestricted volume AED 
procedure trial but half the volume used by Subject 08. 
Concluding Remarks 
Future medical station analysis (MSA) efforts will seek to build upon the baseline established by this 
report. The statistical power of the findings will increase as more caregivers with broader experience 
perform emergent care on a regular basis. Incorporating virtual reality (VR) or augmented reality (AR) 
technology to increase the fidelity of the simulation would allow for the analysis of specific candidate 
designs for the medical station. VR technology would allow researchers to incorporate storage locations 
into the simulation and insert additional environmental factors into the analysis. 
To date, the simulations have occurred in a 1g environment. Future work would benefit from 
incorporating simulations performed in a microgravity environment into the analyses. The reason for this 
is to overcome the 1g bias that might mask opportunities for a more convenient design that are 
independent of any gravity vector. Use of the enhanced Zero-gravity Locomotion Simulator (eZLS) in the 
Exercise Countermeasures Laboratory could help accomplish this objective. 
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Appendix A.—Acronym List 
ADA  AED-assisted CPR, one caregiver, with drug administration 
AED  automated external defibrillator 
AMBU artificial manual breathing unit 
APR  AED-assisted CPR, one caregiver, pulse returns patient becomes responsive 
AR  augmented reality 
AUL  abdominal ultrasound 
BORIS  Behavioral Observation Research Interactive Software 
BZK  benzalkonium 
CAD  computer-aided design 
CCMP Cross-cutting Computational Modeling Project 
CPR  cardiopulmonary resuscitation 
CPU  choking patient becomes unconscious 
CTV  crew task volume 
ECG  electrocardiogram 
ECL  Exercise Countermeasures Laboratory 
eZLS  enhanced Zero-gravity Locomotion Simulator 
IRB  Institutional Review Board 
ISS  International Space Station 
IV   intravenous 
LLO  long–long, opposite sides of table 
LLS  long–long, same side of table 
LSX  long–short, crosswise sides of table 
MSA  medical station analysis 
OCT  optical coherence tomography  
RFT  restricted feet 
RVL  restricted volume large 
RVS  restricted volume small 
SUS  system usability scale 
TLX  task load index 
URV  unrestricted volume 
VR  virtual reality 
VRML virtual reality modeling language 
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Appendix B.—Post-Testing Feedback Questionnaires 
B.1 Subject Post-Session Feedback Questionnaire  
Subjects were given the following questionnaire after completion of each trial: 
 
Name/Title: 
Organizational Affiliation: 
Date of testing: 
Experimenter:  
Scenario:  
 
POST-SESSION QUESTIONNAIRE 
 
1. Were you able to conduct the procedure in this session to a satisfactory level of realism?  
Yes – my actions and times to complete them were representative of how I conduct this 
procedure in real life. 
No – the environment did not permit me to execute this procedure as I would in real life.  
If you answered No, please tell us what was missing or disruptive.  
2. Describe the sufficiency of the spatial allocation to perform the procedures when a fixed volume 
was imposed.  
• Did you feel you were able to conduct the procedure without being hampered by the volume 
available?  
• Even if you felt your performance didn’t suffer due to the volume available, did you feel 
uncomfortable performing the procedure in this space?  
• If you were uncomfortable, please tell us where the space needed to be larger (and by how 
much) for you this discomfort to be relieved.  
3. Please comment on the degree to which your stature and physical characteristics were supported 
by the environment and layout in this scenario. 
4. Describe the challenges you encountered when performing these procedures. What could be done 
to reduce these challenges? 
5. If you were working with another caregiver, describe the way you divided your roles – and how 
you used the space in your role.  
6. If you worked alone on this procedure, what (if anything) would you have asked a second 
caregiver to do if one were available? 
7. We know this is difficult to think about, but if you consider doing this procedure in a 
microgravity environment, what do you think we’d need to change to support that? What would 
you recommend?  
8. Please provide any further thoughts you wish to share.  
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B.2 Subject Post-Study Feedback Questionnaire 
Subjects were given the following questionnaire at the completion of all testing: 
 
Name/Title: 
Organizational Affiliation: 
Date of testing: 
Experimenter:  
 
POST-STUDY QUESTIONNAIRE 
 
1. Try to think about doing these in microgravity, and please comment on the conditions that you 
experienced where there was restricted volumes vs. unrestricted volumes for the same procedure. 
2. Try to think about doing these in microgravity, and please comment on the conditions that you 
experienced, and how well your performance was supported by the environment, when you were 
free-ranging vs. when your feet were restricted to predetermined positions (restriction in general, 
but also the locations tested).  
3. In your professional opinion, was the test setup sufficient to validly evaluate the exploration 
medical station design and determine the operation volume of performing the procedures? If not, 
why not? 
4. Is there anything else you would like to tell us that would influence the design of a medical 
workstation?  
5. Is there anything else you would like to tell us that would help us improve any part of the study 
(design, procedures, hardware, etc.)? 
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Appendix C.—NASA–STD–7009A Compliance 
Table C.1 lists the criteria for the scoring levels as described in NASA–STD–7009A (Ref. 5).  
Table C.2 lists the self-assessment scores and evidence of compliance from the Medical Station Analysis 
Project. 
 
 
TABLE C.1.—KEY ASPECTS OF CREDIBILITY ASSESSMENT LEVELS (FROM REF. 5) 
 Models and simulations (M&S) development M&S use (operations) Supporting evidence 
Level Data  
pedigree 
Verification Validation Input pedigree Uncertainty 
characterization 
Results 
robustness 
M&S history M&S process/ 
product 
management 
4 All data known 
and traceable to 
real-world 
system (RWS) 
with acceptable 
accuracy, 
precision, and 
uncertainty 
Reliable 
practices applied 
to verify the end-
to-end model; all 
model errors 
satisfy 
requirements. 
All M&S outputs 
agree with data 
from the RWS 
over the full 
range of 
operation in its 
real operating 
environment. 
All input data 
known and 
traceable to RWS 
with acceptable 
accuracy, 
precision, and 
uncertainty. 
Statistical 
analysis of the 
output 
uncertainty after 
propagation of 
all known 
sources of 
uncertainty. 
Sensitivities 
known for most 
parameters; most 
key sensitivities 
identified. 
Nearly identical 
model and use. 
Controlled 
processes are 
applied; 
measurements 
used for process 
improvement. 
3 All data known 
and traced to 
sufficient 
referent. 
Significant data 
has acceptable 
accuracy, 
precision, and 
uncertainty. 
Formal practices 
applied to verify 
the end-to-end 
model; all 
important errors 
satisfy 
requirements. 
All key M&S 
outputs agree 
with data from 
the RWS 
operating in a 
representative 
environment. 
All input data 
known and traced 
to sufficient 
referent. 
Significant input 
data has 
acceptable 
accuracy, 
precision, and 
uncertainty. 
Uncertainty of 
results are 
provided 
quantitatively 
through 
propagation of 
all known 
uncertainty. 
Sensitivities 
known for many 
parameters 
including many 
of the key 
sensitivities. 
At most minor 
changes in 
model and at 
most minor 
differences in 
model use. 
Controlled 
processes are 
applied; process 
compliance is 
measured. 
2 Some data 
known and 
formally 
traceable with 
estimated 
uncertainties. 
Documented 
practices applied 
to verify all 
model features; 
most important 
errors satisfy 
requirements. 
Key M&S 
outputs agree 
with data from a 
sufficiently 
similar referent 
system. 
Some input data 
known and 
formally 
traceable with 
estimated 
uncertainties. 
Most sources of 
uncertainty 
identified, 
expressed 
quantitatively, 
and correctly 
classified. 
Propagation of 
the uncertainties 
is assessed. 
Sensitivities 
known for a few 
parameters. Few 
or no key 
sensitivities 
identified. 
At most 
moderate 
changes in 
model and at 
most moderate 
differences in 
model use. 
Formal processes 
are applied. 
1 Some data 
known and 
informally 
traceable. 
Informal 
practices applied 
to verify some 
features of the 
model and assess 
errors. 
Conceptual 
model addresses 
problem 
statement and 
agrees with 
available 
referents. 
Some input data 
known and 
informally 
traceable. 
Sources of 
uncertainty 
identified and 
qualitatively 
assessed. 
Qualitative 
estimates only 
for sensitivities 
in M&S. 
New model or 
major changes in 
model, or major 
differences in 
model use; but, 
model/changes/ 
uses 
documented. 
Informal 
processes are 
applied. 
0 Insufficient 
evidence. 
Insufficient 
evidence. 
Insufficient 
evidence. 
Insufficient 
evidence. 
Insufficient 
evidence. 
Insufficient 
evidence. 
Insufficient 
evidence. 
Insufficient 
evidence. 
 
 
 
 
 
 
 
NASA/TM—2020-220149 58 
TABLE C.2.—SELF-ASSESSMENT SCORES AND EVIDENCE OF COMPLIANCE 
Factor Self 
assessment 
Evidence of compliance 
Data pedigree NA All of the data processing was performed with commercially available or open-source software. 
Verification 
1 
Mathematical checks were used to determine the accuracy of the custom codes used to 
calculate the cuboid volumes and the convex hull volumes. 
Motion capture data collection methods include quantification of the motion capture system 
calibration error. 
Validation 2 Comparison of plots to video data. 
Input pedigree 
3 
Documented data collection procedures based upon industry standards. 
Test plan established prior to data collection. 
Motion data collected from a human subject performing the medical procedures in 1g. 
Results 
uncertainty 1 
The sources of uncertainty have been identified (subject adaptability, anthropometric 
variability, variability in procedure performance due to experience level, training, etc., 
variability due to performing the tasks in 0g versus 1g). 
Results 
robustness NA 
All of the data processing was performed with commercially available or open-source 
software. 
Use history 
1 
Similar analysis methods were used to calculate the operational volume used when 
exercising on exploration exercise devices. An analysis was performed to determine if the 
exercise motions would remain contained within the volume allocated for exercise by the 
Multi-Purpose Crew Vehicle (MPCV) program. 
Models and 
simulations 
(M&S) 
management 
2 
Roles and responsibilities are defined within the analysis plan. 
The Cross-cutting Computational Modeling Project (CCMP) biomechanical modeling effort 
follows NPR 7150.2B and NASA–STD–7009A. 
The codes used for the analysis are available on a NASA shared drive. 
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